IRIS UniCatt

Citterio, Franco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 16.289
NA - Nord America 7.621
AS - Asia 4.670
SA - Sud America 995
Continente sconosciuto - Info sul continente non disponibili 205
AF - Africa 197
OC - Oceania 16
Totale 29.993
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 11.360
US - Stati Uniti d'America 7.400
SG - Singapore 2.292
DE - Germania 1.129
CN - Cina 970
BR - Brasile 781
NL - Olanda 766
SE - Svezia 652
UA - Ucraina 534
FR - Francia 492
VN - Vietnam 387
IE - Irlanda 270
GB - Regno Unito 240
IN - India 185
PL - Polonia 181
ID - Indonesia 171
FI - Finlandia 167
JP - Giappone 127
RU - Federazione Russa 123
CA - Canada 107
BD - Bangladesh 94
ES - Italia 80
TR - Turchia 80
CH - Svizzera 74
HK - Hong Kong 68
IQ - Iraq 63
AR - Argentina 60
MX - Messico 55
BE - Belgio 53
CI - Costa d'Avorio 53
ZA - Sudafrica 39
CO - Colombia 37
EC - Ecuador 31
VE - Venezuela 31
IR - Iran 28
MA - Marocco 26
SA - Arabia Saudita 26
PK - Pakistan 22
AT - Austria 21
CL - Cile 19
KE - Kenya 19
PH - Filippine 18
AL - Albania 15
CZ - Repubblica Ceca 15
EG - Egitto 15
AU - Australia 13
JM - Giamaica 13
RO - Romania 13
UZ - Uzbekistan 13
BG - Bulgaria 12
MY - Malesia 12
AE - Emirati Arabi Uniti 11
GR - Grecia 11
KR - Corea 11
TN - Tunisia 11
LT - Lituania 10
NP - Nepal 10
IL - Israele 9
PE - Perù 9
PT - Portogallo 9
UY - Uruguay 9
DZ - Algeria 8
HN - Honduras 8
PY - Paraguay 8
TH - Thailandia 8
TW - Taiwan 8
AZ - Azerbaigian 7
HU - Ungheria 7
JO - Giordania 7
ET - Etiopia 6
KG - Kirghizistan 6
KZ - Kazakistan 6
NO - Norvegia 6
SI - Slovenia 6
SK - Slovacchia (Repubblica Slovacca) 6
BH - Bahrain 5
BO - Bolivia 5
DK - Danimarca 5
MD - Moldavia 5
NI - Nicaragua 5
A2 - ???statistics.table.value.countryCode.A2??? 4
BB - Barbados 4
EE - Estonia 4
GE - Georgia 4
NG - Nigeria 4
OM - Oman 4
PA - Panama 4
RS - Serbia 4
SM - San Marino 4
AM - Armenia 3
BA - Bosnia-Erzegovina 3
BY - Bielorussia 3
CV - Capo Verde 3
GT - Guatemala 3
GY - Guiana 3
IS - Islanda 3
LC - Santa Lucia 3
MM - Myanmar 3
NZ - Nuova Zelanda 3
PR - Porto Rico 3
Totale 29.743
Salva come PNG Salva come JPEG
Città #
Singapore 1.109
Milan 1.088
Chandler 1.028
Ashburn 885
Rome 788
San Jose 597
Naples 359
Dublin 254
Jacksonville 253
New York 253
San Mateo 246
Beijing 238
Turin 210
Florence 179
Wilmington 165
Bologna 154
Jakarta 153
Palermo 143
Ho Chi Minh City 133
Lauterbourg 133
Los Angeles 130
Nanjing 129
Ann Arbor 127
Boston 126
Hanoi 118
Bari 113
Fairfield 111
Catania 106
Tokyo 101
Warsaw 99
Genoa 98
Lawrence 94
Cattolica 93
Dallas 79
Dearborn 79
Verona 77
Chicago 72
Houston 71
Redwood City 67
Buffalo 66
Moscow 66
Frankfurt am Main 63
Brescia 60
Hong Kong 60
Santa Clara 59
São Paulo 58
The Dalles 58
Seattle 55
Princeton 54
Abidjan 53
Kraków 50
Nürnberg 49
Woodbridge 49
Padova 45
Hefei 44
Munich 44
Orem 43
Parma 41
Reggio Emilia 41
Venice 41
Helsinki 40
Brussels 39
Cagliari 39
Guangzhou 39
Nanchang 39
Taranto 39
Bergamo 38
Rio de Janeiro 37
Pescara 36
Redmond 35
Madrid 34
Mountain View 34
Perugia 34
San Francisco 34
Messina 33
Boardman 31
Brooklyn 31
London 31
Toronto 31
Paris 30
Hangzhou 29
Lancaster 29
Livorno 28
Shenyang 28
Norwalk 27
University Park 27
Atlanta 26
Izmir 26
Lucca 26
Amsterdam 25
Augusta 25
Hebei 25
Salerno 25
Montreal 24
Phoenix 24
Belo Horizonte 23
Marseille 23
Modena 23
Monza 23
Rimini 23
Totale 12.570
Salva come PNG Salva come JPEG
Nome #
Le disfunzioni sessuali maschili in pazienti con insufficienza renale cronica end stage ed in pazienti sottoposti a trapianto renale 12.320
Process control: simply a matter of efficiency or of survival and costs? A single-centre quality improvement project in living donor renal transplant 207
Accidental transplantation of a kidney with stones: case report 201
Increased cancer risk in patients undergoing dialysis: A population-based cohort study in North-Eastern Italy 196
Emotional self-efficacy and alexithymia may affect compliance, renal function and quality of life in kidney transplant recipients: results from a preliminary cross-sectional study 195
Expanding the living donor pool, "Ist Act": analysis of the causes of exclusion of potential kidney donors. 191
[Laws regulating transplantation should express the contemporaneity. Questions to the constitutionalist Francesco Paolo Casavola and to the philosophers Remo Bodei and Aldo Masullo about the possibility deciding the destiny of one's own organs at the time one decides on how to die and on contacts between donor families and recipients.] 191
N-Acetylcysteine and High-Dose Atorvastatin Reduce Oxidative Stress in an Ischemia-Reperfusion Model in the Rat Kidney 190
Contrast-enhanced Voiding US for Grading of Reflux in Adult Patients Prior to Antireflux Ureteral Implantation1 188
Effects of switching from twice-daily to once-daily tacrolimus formulation on quality of life, anxiety, and transplant benefit perception after kidney transplantation 185
Attachment style predict compliance, quality of life and renal function in adult patients after kidney transplant: preliminary results 181
HIGH-DOSE ATORVASTATIN REDUCE OXIDATIVE STRESS OF ISCHEMIA/REPERFUSION INJURY AFTER ISOGENEIC KIDNEY TRANSPLANTATION IN RATS 180
LAPDOCTOR: TELL ME HOW DIFFICULT WILL BE MY DONOR 180
Effects of Switching from Twice-Daily to Once-Daily Tacrolimus Formulation on Quality of Life, Anxiety, and Transplant Benefit Perception after Kidney Transplantation 177
Expanding the Living Donor Pool "Second Act": Laparoscopic Donor Nephrectomy and ABO-Incompatible Kidney Transplantation Improve Donor Recruitment 176
Expanding the Living Donor Pool "Second Act": Laparoscopic Donor Nephrectomy and ABO-Incompatible Kidney Transplantation Improve Donor Recruitment 169
Early Appearance of De Novo Anti-HLA Antibodies Following Renal Transplantation: Preliminary Results of a Prospective Multicenter Study. 168
Belatacept utilization recommendations: an expert position 165
RENAL FUNCTION IN PATIENTS TREATED WITH BELATACEPT-OR CYCLOSPORINE-BASED REGIMENS AT YEAR 3 IN THE BENEFIT AND BENEFIT-EXT STUDIES 161
Significant improvement in patient survival after renal transplantation in the last decade. 159
Living Kidney Donation in a Type 1 Dent's Disease Patient from His Mother 159
Late Calcineurin Inhibitors Introduction after Induction with Basiliximab and Thymoglobulin Is Safe and Effective in Old for Old Renal Transplantation: 1-Year Results of a Prospective Clinical Study. 156
USE OF A SINGLE DOSE OF BASILIXIMAB AFTER MAJOR SURGICAL PROCEDURES IN KIDNEY TRANSPLANT RECIPIENTS 155
TO TRANSPLANT OR NOT TO TRANSPLANT: A KIDNEY WITH A GIANT CYST. CASE REPORT AND REVIEW OF THE LITERATURE 155
Once Daily Everolimus Is Safe and Effective in De Novo Renal Transplant Recipients: Six-Month Results of a Pilot Study. 154
CHYLOUS ASCITES AFTER LAPAROSCOPIC LIVING DONOR NEPHRECTOMY. CASE REPORT AND REVIEW OF THE LITERATURE 152
Preoperative Psychological Factors Predicting Graft Rejection in Patients Undergoing Kidney Transplant: A Pilot Study 151
COMBINATION OF EXTENDED-RELEASE TACROLIMUS PLUS EVEROLIMUS ONCE-DAILY IN DE NOVO KIDNEY TRANSPLANT RECIPIENTS: ER-TAC VERSUS LCPT 151
Metabolic Syndrome and Cardiovascular Disease in Kidney Transplantation 148
Attachment style predict compliance, quality of life and renal function in adult patients after kidney transplant: preliminary results. 147
ONE-SHOT VERSUS MULTIDOSE PERIOPERATIVE ANTIBIOTIC PROPHYLAXIS AFTER KIDNEY TRANSPLANTATION: A RANDOMIZED, CONTROLLED, CLINICAL TRIAL 147
Complete clinical remission of psoriasis 6 months after renal transplantation 143
Do patients who participate in a clinic experimental protocol have the same probability of success from that who were not selected or refused to participate? Outcome surveillance, safety, and bioethical considerations in kidney transplant clinical research 143
Interventional radiological treatment of renal transplant complications: a pictorial review 143
Bullous pemphigoid in a transplant recipient: is this a sign of allograft rejection? 142
Perioperative-, recipient-, and donor-related factors affecting delayed graft function in kidney transplantation 142
INCIDENCE AND RISK FACTORS FOR DE-NOVO CANCERS IN ITALIAN KIDNEY TRANSPLANT (KT) RECIPIENTS 141
AN EASY ALGORITHM TO OPTIMIZE THE EXPOSURE TO TACROLIMUS AND EVEROLIMUS, WHEN USED IN COMBINATION 140
The reduction of left ventricular hypertrophy after renal transplantation is not influenced by the immunosuppressive regimen. 138
Bullous pemphigoid in a transplant recipient: is this a sign of allograft rejection? 137
How Challenging Will Be My Living Donor? CT Scan and Clinical Evaluation Can Predict Technical Difficulty of Laparoscopic Donor Nephrectomy 137
Tacrolimus plus mycophenolate mofetil vs. cyclosporine plus everolimus in deceased donor kidney transplant recipients: three-yr results of a single-center prospective clinical trial. 136
Behavioural and demographic factors associated with occurrence of non-melanoma skin cancer in organ transplant recipients 135
Extended-Release Tacrolimus Plus Everolimus or Micophenolate Mofetil in Deceased Donor Kidney Transplant Recipients: 6-Month Results of a Prospective Randomized Clinical Trial 134
Emotional self-efficacy and alexithymia may affect compliance, renal function and quality of life in kidney transplant recipients: Results from a preliminary cross-sectional study 133
Summary of the International Conference on Onco-Nephrology: an emerging field in medicine 133
PRELIMINARY RESULTS FROM A PROSPECTIVE MULTICENTER STUDY REVEAL THE EARLY APPEARANCE OF DE NOVO ANTI-HLA ANTIBODIES FOLLOWING RENAL TRANSPLANTATION 132
Combination of Extended-Release Tacrolimus Plus Everolimus Once Daily in Dc Novo Kidney Transplant Recipients: ER-Tac vs LCPT 132
Determinants of hemodynamic compensation during veno-venous bypass in liver transplantation 131
Increase in N-acetyl-beta-glucosaminidase excretion as a marker of kidney damage in cyclosporine-treated renal allografts 131
Living kidney donation from people at risk of nephrolithiasis, with a focus on the genetic forms 131
Wound Healing Complications and the Use of Mammalian Target of Rapamycin Inhibitors in Kidney Transplantation: A Critical Review of the Literature 129
Conversion from Prograf to Advagraf in stable kidney transplant recipients: better renal function after 3-year follow-up 129
Posttransplant encapsulating peritoneal sclerosis, long-term success with everolimus and low-dose CNI: a case report 128
Behavioral and demographic factors associated with occurrence of non-melanoma skin cancer in organ transplant recipients 128
Andamento temporale di alcune proteine della fase acuta dopo trapianto di rene 127
Belatacept utilization recommendations: an expert position 125
Interventional Radiological Treatment of Renal Transplant Complications: A Pictorial Review 123
Inferior Long-Term Outcomes for Kidney Transplant Recipients With an Immunologically Mediated Primary Renal Disease 123
Evaluation of Everolimus Activity against Mycobacterium tuberculosis Using In Vitro Models of Infection 121
Bullous pemphigoid in a transplant recipient: is this a sign of allograft rejection? 121
Increased incidence of cutaneous melanoma in organ transplant recipients based on a single-centre longitudinal study in Rome, Italy. 121
Coenzyme Q. alpha tocopherol graft uptake and lipid peroxidation in human liver transplantation: evidence of energy metabolism protection in University of Wisconsin (UW) solution-preserved livers 119
Nonadherence to immunosuppressive therapy in kidney transplant recipients: can technology help? 119
"Why can't I give you my organs after my heart has stopped beating?" An overview of the main clinical, organisational, ethical and legal issues concerning organ donation after circulatory death in Italy 119
Immunosuppression with Belatacept-Based, Corticosteroid-Avoiding Regimens in De Novo Kidney Transplant Recipients 118
Emotional management and quality of life in mother living versus multi-organ donor renal transplant recipients 118
Anonymity and live-donor transplantation: an ELPAT view 117
[Nitrogen loss after kidney transplantation: effects of immunosuppressive therapy] 117
Global Kidney Exchange: opportunity or exploitation? An ELPAT/ESOT appraisal 117
Thymoglobulin and Basiliximab vs Basiliximab as Induction Therapy in Deceased Donor Kidney Transplantation: 1-Year Results of a Prospective Clinical Trial 115
Evolution of causes of mortality in renal transplantation in the last 10 years 115
COVID-19 and kidney transplantation: an Italian Survey and Consensus 115
Pharmacokinetics for once- versus twice-daily tacrolimus formulations in de novo kidney transplantation: a randomized, open-label trial 114
The Relevance of Directive 2010/53/EU for Living Organ Donation Practice: An ELPAT View 114
De Novo Malignancies after Organ Transplantation: Focus on Viral Infections 113
Radiofrequency thermal ablation of renal graft neoplasms: A literature review 113
Once-a-Day Administration of Everolimus Is Safe in De Novo Renal Transplant Recipients: 1-Year Results of a Pilot Study 112
Isoprinosine effects on postoperative immunodepression 112
Spontaneous renal allograft rupture complicated by urinary leakage: case report and review of the literature 112
Two-year outcomes in de novo renal transplant recipients receiving everolimus-facilitated calcineurin inhibitor reduction regimen from the TRANSFORM study 112
Prediction, prevention, and management of delayed graft function: where are we now? 111
Enzyme-Linked Immunospot Assay as a Complementary Method to Assess and Monitor Cytomegalovirus Infection in Kidney Transplant Recipients on Pre-emptive Antiviral Therapy: A Single-Center Experience 111
Safety of Everolimus With Reduced Calcineurin Inhibitor Exposure in De Novo Kidney Transplants: An Analysis From the Randomized TRANSFORM Study 110
Preoperative psychological factors predicting graft rejection in patients undergoing kidney transplant: a pilot study 109
Dealing With Public Solicitation of Organs From Living Donors-An ELPAT View 109
Human humoral immune reactions against pig antigens: a method to clear preexisting preformed natural antibodies 108
Once-a-day administration of everolimus is safe in de novo renal transplant recipients: 1-year results of a pilot study 108
Immunosoppressive Therapy and Risk of Post-Transplant Malignancies after Kidney Transplantation: Italian Multicentric Study 106
Expanding the living donor pool, "Ist Act": analysis of the causes of exclusion of potential kidney donors 106
Everolimus and Minimization of Cyclosporine in Renal Transplantation: 24-Month Follow-Up of the EVEREST Study 105
Cyclosporine levels together with metabolites are more effective than cyclosporine parent compound levels alone in predicting hepatic toxicity after liver transplantation 103
Effects of switching from twice-daily to once-daily tacrolimus formulation on quality of life, anxiety, and transplant benefit perception after kidney transplantation 103
Dealing With Public Solicitation of Organs From Living Donors--An ELPAT View 103
Everolimus with Reduced Calcineurin Inhibitor Exposure in Renal Transplantation 103
Preoperative psychological factors predicting graft rejection in patients undergoing kidney transplant: a pilot study 102
Belatacept utilization recommendations: an expert position 101
Raising awareness of unspecified living kidney donation: An ELPAT 101
Risk of de novo cancers after transplantation: results from a cohort of 7217 kidney transplant recipients, Italy 1997-2009 100
Immunosuppression with belatacept-based, corticosteroid-avoiding regimens in de novo kidney transplant recipients 100
Totale 25.754
Salva come PNG Salva come JPEG
Categoria #
all - tutte 91.412
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 91.412
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.127 0 0 27 52 46 55 37 227 49 98 267 269
2022/20233.797 332 348 192 452 177 432 152 343 495 203 385 286
2023/20244.961 284 576 300 374 340 488 402 417 349 444 487 500
2024/20257.190 492 664 689 565 691 508 517 589 823 439 662 551
2025/20267.436 1.199 335 492 641 1.191 398 1.189 477 520 529 232 233
2026/20271.297 415 417 465 0 0 0 0 0 0 0 0 0
Totale 29.993